Analysis of association of rs9536314 of the KL gene with anthropometric and biochemical indicators in men of Novosibirsk (West Siberia)

Purpose of the study. To determine the frequency of the rs9536314 (F325V) polymorphism of the KL gene and the association of this variant with a number of biochemical and anthropometric parameters in men of the study group and in the Caucasian population of Western Siberia.

Materials and methods. The study group (69 men, average age 61.2 ±11.5 years) was randomly formed  from a sample of persons who applied to the clinic and polyclinic of NIITPM - a branch of the ICG SB RAS and GBUZ NSO Hospital of war veterans No. 3 (178 men, aged 50-65 years old and over 80 years old). The population group was randomly selected (219 people) from the sample surveyed within the framework of the International Multicenter Project "Risk Factors for Cardiovascular Diseases in Eastern Europe" HAPIEE (9360 participants, 45–69 years old, mean age 53.8±7 years old, Caucasians > 90 %). Biochemical parameters were determined by standard enzymatic methods. Serum concentration of Klotho protein was measured by ELISA. Genomic DNA was amplified by polymerase chain reaction in a standard reaction mixture and further digested with TaqI B restriction enzyme.

Results. The frequency of genotypes (TT, TG, and GG) and alleles (T and G) rs9536314 of the KL gene in the study group corresponds to the data in the population of Western Siberia, as well as the population of Western and Eastern Europe. There were no statistically significant differences in the mean values of the studied clinical and biochemical parameters depending on the rs9536314 genotypes of the KL gene in the study group and in the population. In the study group, the level of Klotho protein in the blood and the glomerular filtration rate in men with coronary heart disease and arterial hypertension did not differ in the autosomal dominant and autosomal recessive models for the rs9536314 KL gene.

Conclusion. Thus, the frequency of the rs9536314 polymorphism of the KL gene in the study group corresponds to the frequency of the rs9536314 polymorphism of the KL gene in the Caucasian population of Western Siberia. Biochemical and anthropometric parameters, as well as the Klotho protein, do not have statistically significant differences depending on the genotypes of rs9536314 of the KL gene in the examined men. 

1. Kuro-o M., Matsumura Y., Aizawa H. Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A., Shiraki-Iida T., Nishikawa S., Nagai R., Nabeshima Y.I. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature, 1997; 390 (6655): 45–51. doi: 10.1038/36285

2. Matsumura Y., Aizawa H., Shiraki-Iida T. Nagai R., Kuro-o M., Nabeshima Y. Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem. Biophys. Res. Commun., 1998; 242 (3): 626–630. doi: 10.1006/bbrc.1997.8019

3. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., McGuinness O.P., Chikuda H., Yamaguchi M., Kawaguchi H., Shimomura I., Takayama Y., Herz J., Kahn C.R., Rosenblatt K.P., Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science, 2005; 309 (5742), 1829–1833. doi: 10.1126/science.1112766

4. Li S.A., Watanabe M., Yamada H., Nagai A, Kinuta M, Takei K. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct. Funct., 2004; 29 (4): 91–99. doi: 10.1247/csf.29.91

5. Arking D.E., Krebsova A., Macek M.Sr., Macek M.Jr., Arking A., Mian I.S., Fried L., Hamosh A., Dey S., McIntosh I., Dietz H.C. Association of human aging with a functional variant of Klotho. Proc. Natl. Acad. Sci. USA, 2002; 99 (2): 856–861. doi: 10.1073/pnas.022484299

6. Shardell M., Semba R.D., Rosano C., Kalyani R.R., Bandinelli S., Chia C.W. L plasma Klotho and cognitive decline in older adults: findings from the InCHIANTI study. J. Gerontol. A. Biol. Sci. Med. Sci., 2016; 71 (5): 677–682. doi: 10.1093/gerona/glv140

7. Prather A.A., Epel E.S., Arenander J., Broestl L., Garay B.I., Wang D., Dubal D.B. Longevity factor klotho and chronic psychological stress. Transl. Psychiatry, 2015; 5 (6): e585. doi: 10.1038/tp.2015.81

8. Dubal D.B., Zhu L., Sanchez P.E., Worden K., Broestl L., Johnson E., Ho K., Yu G.Q., Kim D., Betourne A., Kuro-O M., Masliah E., Abraham C.R., Mucke L. Life extension factor Klotho prevents mortality and enhances cognition in hAPP transgenic

9. mice. J. Neurosci., 2015; 35 (6): 2358–2371. doi: 10.1523/JNEUROSCI.5791-12.2015

10. Abulizi P., Zhou X.-H., Keyimu K., Luo M., Jin F.-Q. Correlation between Klotho gene and mild cognitive impairment in the Uygur and Han populations of Xinjiang. Oncotarget, 2017; 8 (43): 75174–75185. doi: 10.18632/oncotarget.20655

11. Deary I.J., Harris S.E., Fox H.C., Hayward C., Wright A.F., Starr J.M., Whalley L.J. Klotho genotype and cognitive ability in childhood and old age in the same individuals. Neurosci. Lett., 2005; 378 (1): 22–27. doi: 10.1016/j.neulet.2004.12.005

12. Mengel-From J., Soerensen M., Nygaard M., McGue M., Christensen K., Christiansen L. Genetic variants in Klotho associate with cognitive function in the oldest old group. J. Gerontol. A. Biol. Sci. Med. Sci., 2016; 71 (9): 1151–1159. doi: 10.1093/gerona/glv163

13. Marchelek-Myśliwiec M., Różański J., Ogrodowczyk A., Dutkiewicz G., Dołęgowska B., Sałata D., Budkowska M., Safranow K., Stępniewska J., Wiśniewska M., Ciechanowski K. The association of the Klotho polymorphism rs9536314 with parameters of calciumphosphate metabolism in patients on long-term hemodialysis. Ren. Fail., 2016; 38 (5): 776–780. doi: 10.3109/0886022X.2016.1162062

14. Arking D.E., Becker D.M., Yanek L.R., Fallin D., Judge D.P., Moy T.F., Becker L.C., Dietz H.C. Klotho allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet., 2003; 72 (5): 1154–1161. doi: 10.1086/375035

15. Yokoyama J.S., Sturm V.E., Bonham L.W., Klein E., Arfanakis K., Yu L., Coppola G., Kramer J.H., Bennett D.A., Miller B.L., Dubal D.B. Variation in longevity gene Klotho is associated with greater cortical volumes. Ann. Clin. Transl. Neurol, 2015; 2 (3): 215–230. doi: 10.1002/acn3.161

16. Arking D.E., Atzmon G., Arking A., Barzilai N., Dietz H.C. Association between a functional variant of the Klotho gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res., 2005; 96 (4): 412–418. doi: 10.1161/01.RES.0000157171.04054.30

17. Zhu Z., Xia W., Cui Y., Zeng F., Li Y., Yang Z., Hequn C. Klotho gene polymorphisms are associated with healthy aging and longevity: Evidence from a meta-analysis. Mech. Ageing Dev, 2019; 178: 33–40. doi:10.1016/j.mad.2018.12.003

18. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods, 2010; 7 (4): 248–249. doi: 10.1038/nmeth0410-248

19. Peasey A., Bobak M., Kubinova R., Malyutina S.K., Pajak A., Tamosiunas A., Pikhart H., Nicholson A., Marmot M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and Design of the HAPIEE study. BMC Public Health, 2006; (6): 255–264. doi: 10.1186/1471-2458-6-255

20. Sambrook J., Russell D.W. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc. 2006; (1): pdb.prot4455. doi: 10.1101/pdb.prot4455

21. Тимощенко О.В., Рагино Ю.И., Стахнева Е.М., Каштанова Е.В., Никитин Ю.П. Белок Клото в крови у мужчин с ишемической болезнью сердца и его ассоциации с липидным профилем. Атеросклероз, 2020; 16 (1): 5–8. doi.org/10.15372/ATER20200101

22. Тимощенко О.В., Стахнева Е.М., Рагино Ю.И., Никитин Ю.П. Особенности содержания белка Клото в крови у мужчин с артериальной гипертонией и его ассоциации с кардиометаболическими факторами риска. Комплексные проблемы сердечно-сосудистых заболеваний, 2020; 9 (4): 21–31. https://doi.org/10.17802/2306-1278-2020-9-4-21-31

23. Aizawa H., Saito Y., Nakamura T., Inoue M., Imanari T., Ohyama Y., Matsumura Y., Masuda H., Oba S., Mise N., Kimura K., Hasegawa A., Kurabayashi M., Kuro-o M., Nabeshima Y., Nagai R. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem. Biophys. Res. Commun., 1998; 249 (3): 865–871. doi: 10.1006/bbrc.1998.9246

24. Nagai R., Saito Y., Ohyama Y., Aizawa H., Suga T., Nakamura T., Kurabayashi M., Kuroo M. Endothelial dysfunction in the Klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell. Mol. Life Sci., 2000; 57 (5): 738–746. doi: 10.1007/s000180050038

25. Mitani H., Ishizaka N., Aizawa T., Ohno M., Usui S., Suzuki T., Amaki T., Mori I., Nakamura Y., Sato M., Nangaku M., Hirata Y., Nagai R. In vivo Klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension, 2002; 39 (4): 838–843. doi: 10.1161/01.hyp.0000013734.33441.ea

26. Brunner H.R. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am. J. Cardiol., 2001; 87 (8A): 3C–9C. doi: 10.1016/s0002-9149(01)01538-7

27. Gavras I., Gavras H. Angiotensin II as a cardiovascular risk factor. J. Hum. Hypertens., 2002; 16 (Suppl. 2): S2–S6. doi: 10.1038/sj.jhh.1001392

28. Saito Y., Yamagishi T., Nakamura T., Ohyama Y., Aizawa H., Suga T., Matsumura Y., Masuda H., Kurabayashi M., Kuro-o M., Nabeshima Y., Nagai R. Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun., 1998; 248 (2): 324–329. doi: 10.1006/bbrc.1998.8943

29. Saito Y., Nakamura T., Ohyama Y., Suzuki T., Iida A., Shiraki-Iida T., Kuro-o M., Nabeshima Y., Kurabayashi M., Nagai R. In vivo Klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun., 2000; 276 (2): 767–772. doi: 10.1006/bbrc.2000.3470

30. Fukino K., Suzuki T., Saito Y., Shindo T., Amaki T., Kurabayashi M., Nagai R. Regulation of angiogenesis by the aging suppressor gene Klotho. Biochem. Biophys. Res. Commun., 2002; 293 (1): 332–337. doi: 10.1016/S0006-291X(02)00216-4

31. Yuhanna I.S., Zhu Y., Cox B.E., Hahner L.D., Osborne-Lawrence S., Lu P., Marcel Y.L., Anderson R.G., Mendelsohn M.E., Hobbs H.H., Shaul P.W. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med., 2001; 7 (7): 853–857. doi: 10.1038/89986

32. Kuvin J.T., Rämet M.E., Patel A.R., Pandian N.G., Mendelsohn M.E., Karas R.H. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am. Heart J., 2002; 144 (1): 165–172. doi: 10.1067/mhj.2002.123145